The inflammatory cytokine IL-6 contributes to the growth and progression of various malignancies, such as HNSCC, prostate cancer and gastrointestinal cancer, and acts as an autocrine growth factor and an anti-apoptotic factor for various stimuli, including anticancer agents [11,24-27]. This evidence concerns the gene IL6 and prostate carcinoma.